Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) EBT Margin (2018 - 2025)

Historic EBT Margin for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to 501.92%.

  • Bicycle Therapeutics' EBT Margin rose 15253600.0% to 501.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 4509.57%, marking a year-over-year increase of 73561200.0%. This contributed to the annual value of 14967.5% for FY2024, which is 115150500.0% down from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' EBT Margin is 501.92%, which was up 15253600.0% from 2711.75% recorded in Q2 2025.
  • Bicycle Therapeutics' EBT Margin's 5-year high stood at 321.52% during Q4 2023, with a 5-year trough of 2711.75% in Q2 2025.
  • In the last 5 years, Bicycle Therapeutics' EBT Margin had a median value of 619.84% in 2025 and averaged 802.09%.
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 20950300bps in 2022, then crashed by -22876800bps in 2025.
  • Bicycle Therapeutics' EBT Margin (Quarter) stood at 2481.12% in 2021, then surged by 84bps to 386.1% in 2022, then surged by 183bps to 321.52% in 2023, then tumbled by -40bps to 193.47% in 2024, then plummeted by -359bps to 501.92% in 2025.
  • Its EBT Margin was 501.92% in Q3 2025, compared to 2711.75% in Q2 2025 and 619.84% in Q1 2025.